An Epidemiological Study Aimed to Record Standard Daily Practice in Managing Patients With Hypercholesterolemia
NCT01206231 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 330
Last updated 2011-11-08
Summary
This study is aimed to collect the following Serbia-specific epidemiology data on hypercholesterolemia: patents characteristics, patients' management/treatment and physicians' standard practice. In addition, the aim is to determine the proportion of patients on lipid-lowering pharmacological treatment who have reached the LDL-C and HDL-C treatment goals.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Prof.Dr Miodrag Ostojic · Division of Cardiology-Clinical Centre of Serbia-Belgrade
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-12-31
- Primary Completion
- 2011-10-31
- Completion
- 2011-10-31
Countries
- Serbia
Study Locations
More Related Trials
-
Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia
NCT01604733 ·Status: COMPLETED
-
Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia
NCT01025388 ·Status: COMPLETED
-
Survey of Lipid Goal Attainment and Mortality in Patients With High Cardiovascular Risk in Thailand
NCT00684151 ·Status: COMPLETED
-
Centralized Pan-Middle East Survey on the Under-treatment of Hypercholesterolemia, Sub-study for the Gulf States
NCT01031277 ·Status: COMPLETED
-
Ezetimibe-Rosuvastatin Evaluation Study
NCT03947866 ·Status: UNKNOWN
-
Dyslipidemia Treatment in Thailand and Cardiovascular Outcomes
NCT01265836 ·Status: WITHDRAWN
-
An Observational Study Evaluating Cholesterol Levels in Patients on Cholesterol Lowering Drugs in Jordan and Lebanon
NCT01614561 ·Status: COMPLETED
-
Centralized Pan-South African Survey on the Undertreatment of Hypercholesterolaemia
NCT01027624 ·Status: COMPLETED
-
Lipid Management in Clinical Practice (MK-0524A-115)
NCT01071278 ·Status: COMPLETED
-
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event
NCT07000123 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Opinion of Patients Under Treatment That Meets the Criteria of New Treatment Strategy According to GINA 2006
NCT00695357 ·Status: COMPLETED
-
Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED)
NCT00092833 ·Status: TERMINATED ·Phase: PHASE3
-
A Controlled-Study of Fenofibrate 145 mg and Ezetimibe 10 mg in Type IIb Dyslipidemic Patients With Features of the Metabolic Syndrome
NCT00349284 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Safety, Efficacy and Tolerability of AZD8233 Treatment in Participants With Hyperlipidaemia
NCT04964557 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia
NCT06173570 ·Status: COMPLETED ·Phase: PHASE2
-
Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets
NCT00536965 ·Status: COMPLETED
-
Fluvastatin 80 mg Ret. vs Combination With Ezetimibe 10 mg in Patients With High Cardiovascular Risk
NCT00814723 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Dyslipidemia Prevalence, Perception, Treatment, and Awareness in the Tunisian Population
NCT03799185 ·Status: COMPLETED
-
Comparative Atorvastatin Pleiotropic Effects
NCT00163202 ·Status: COMPLETED ·Phase: PHASE4
-
Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED)
NCT00651963 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Study to Understand Patients' and Physicians' Attitudes to Statins in TurkeY
NCT01625884 ·Status: COMPLETED
-
A Study Evaluating the Safety and Efficacy of AVE5530 (4 Weeks) in Patients With Mild to Moderate Hypercholesterolemia
NCT00440154 ·Status: COMPLETED ·Phase: PHASE2
-
Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets
NCT00536796 ·Status: COMPLETED
-
Ezetimibe Plus Simvastatin Versus Simvastatin Alone in African-American Subjects With Primary Hypercholesterolemia (P03377)
NCT00650663 ·Status: COMPLETED ·Phase: PHASE4